Fasting and post-prandial glucagon like peptide 1 and oral contraception in polycystic ovary syndrome

Aydin K., Arusoglu G., KÖKSAL G., Cinar N., Aksoy D. Y. , Yildiz B. O.

CLINICAL ENDOCRINOLOGY, vol.81, no.4, pp.588-592, 2014 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 81 Issue: 4
  • Publication Date: 2014
  • Doi Number: 10.1111/cen.12468
  • Journal Indexes: Science Citation Index Expanded, Scopus
  • Page Numbers: pp.588-592


ObjectiveWe aimed to investigate whether fasting and meal regulated glucagon like peptide 1 (GLP-1) secretion are altered in patients with polycystic ovary syndrome (PCOS) compared to healty women and whether oral contraceptive use influence GLP-1 secretion dynamics in the syndrome.